Virtus ETF Advisers’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,970
| Closed | -$65.3K | – | 267 |
|
|
2024
Q4 | $65.3K | Sell |
19,970
-9,192
| -32% | -$30.1K | 0.03% | 418 |
|
|
2024
Q3 | $112K | Buy |
29,162
+515
| +2% | +$1.98K | 0.05% | 359 |
|
|
2024
Q2 | $88.5K | Buy |
+28,647
| New | +$88.5K | 0.04% | 366 |
|
|
2023
Q4 | – | Sell |
-40,040
| Closed | -$81.3K | – | 426 |
|
|
2023
Q3 | $81.3K | Sell |
40,040
-3,984
| -9% | -$8.09K | 0.05% | 358 |
|
|
2023
Q2 | $101K | Buy |
44,024
+6,827
| +18% | +$15.7K | 0.06% | 374 |
|
|
2023
Q1 | $113K | Sell |
37,197
-14,299
| -28% | -$43.3K | 0.06% | 329 |
|
|
2022
Q4 | $120K | Buy |
51,496
+8,508
| +20% | +$19.8K | 0.06% | 416 |
|
|
2022
Q3 | $82K | Buy |
42,988
+313
| +0.7% | +$597 | 0.03% | 427 |
|
|
2022
Q2 | $116K | Buy |
42,675
+5,227
| +14% | +$14.2K | 0.04% | 394 |
|
|
2022
Q1 | $112K | Sell |
37,448
-2,227
| -6% | -$6.66K | 0.05% | 283 |
|
|
2021
Q4 | $154K | Buy |
+39,675
| New | +$154K | 0.06% | 340 |
|
|
2016
Q2 | – | Sell |
-54,471
| Closed | -$225K | – | 146 |
|
|
2016
Q1 | $225K | Buy |
+54,471
| New | +$225K | 0.31% | 71 |
|